tadalafil has been researched along with Adverse Drug Event in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Li, AS; Pomeranz, HD | 1 |
| Fukimbara, S; Odani, M; Sato, T | 1 |
| Dardi, F; Denton, CP; Esler, A; Galiè, N; Harmon, C; Li, B; Manes, A; Mazzanti, G; Palazzini, M; Varanese, L | 1 |
| Del Popolo, G; Lombardi, G; Macchiarella, A | 1 |
| Hwang, EC; Kim, SO; Park, K | 1 |
| Wolfe, SM | 1 |
| Chan, M; Cheong, NF; Ding, Q; Guo, YL; Lim, E; Pan, TM; Shen, W; Venugopalan, M; Wang, YX; Zhu, JC | 1 |
1 review(s) available for tadalafil and Adverse Drug Event
| Article | Year |
|---|---|
Prevalence and medical management of erectile dysfunction in Asia.
Topics: Adult; Aged; Asia; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prevalence; Purines; Pyrimidines; Pyrimidinones; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfonamides; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2011 |
3 trial(s) available for tadalafil and Adverse Drug Event
| Article | Year |
|---|---|
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease.
Topics: Connective Tissue Diseases; Dose-Response Relationship, Drug; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Physical Examination; Tadalafil; Treatment Outcome; Vasodilator Agents | 2017 |
Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis.
Topics: Adult; Carbolines; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Phosphodiesterase 5 Inhibitors; Quality of Life; Tadalafil; Treatment Outcome | 2010 |
Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
Topics: Adult; Aged; Aged, 80 and over; Asia, Southeastern; Carbolines; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase Inhibitors; Tadalafil | 2006 |
5 other study(ies) available for tadalafil and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use.
Topics: Adverse Drug Reaction Reporting Systems; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Phosphodiesterase 5 Inhibitors; Product Surveillance, Postmarketing; Pyrimidines; Retinal Artery Occlusion; Retinal Vein Occlusion; Sildenafil Citrate; Tadalafil; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride | 2016 |
A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
Topics: Bayes Theorem; Drug-Related Side Effects and Adverse Reactions; Humans; Lower Urinary Tract Symptoms; Male; Meta-Analysis as Topic; Models, Statistical; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Tadalafil | 2017 |
There have been inadequate warnings that erectile dysfunction drugs can cause blindness.
Topics: Blindness; Carbolines; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Erectile Dysfunction; Humans; Imidazoles; Incidence; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Assessment; Risk Factors; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; United States; Vardenafil Dihydrochloride; Vasodilator Agents; Video Recording | 2005 |